TOGETHER WE SOAR | A Message From Eagle’s President & CEO

 

Blue & White Testimonial Icon Quotation Marks1

Our desire, dedication, and discipline to ensure that patient safety is at the forefront of everything we do and our holistic approach to resolving your compliance needs make Eagle a truly unique organization.

Eagle was established two decades ago to meet the regulatory needs and requirements of the pharmaceutical industry. During that time, Eagle grew and morphed into a full-fledged analytical chemistry and microbiological testing laboratory and consulting firm. In the coming decade, Eagle will continue building greater capabilities so that we can meet new market demands.

We are committed to providing your organization with the tools and knowledge to operate and maintain compliance within a highly regulated environment. Our science and pharmaceutical experts, state-of-the-art equipment, dynamic systems, and advanced procedures allow us to offer superior customized services.

Our desire, dedication, and discipline to ensure that patient safety is at the forefront of everything we do and our holistic approach to resolving your compliance needs make Eagle a truly unique organization.

We thank you for allowing us to assist you. We pride ourselves on being a valuable resource for you and look forward to facing future challenges together.

Sincerely,

 

 

Ross A. Caputo

President & CEO

 

Patents by Dr. Ross Caputo, Ph.D.

Ross A. Caputo has filed for patents to protect several inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO). Click here to view patents.

 

Publications by Dr. Ross Caputo, Ph.D.
  1. Caputo, R., A. Huffman, and R.R. Reich, 2005, “Practical Solutions for Microbiology, Sterility and Pyrogen Testing” in International Journal of Pharmaceutical Compounding, Vol. 9, No.1. January/February 2005. Pp 9-12.
  2. Reich, R.R. and R. Caputo, 2004. “Vapor Phase Hydrogen Peroxide Resistance of Environmental Isolates” in Pharmaceutical Technology, August 2004.
  3. Jeffrey, J. Koeller, J. Zdunek, R. Byrne, and R.A. Caputo. Validation of an Enhanced Method of Bacterial Ribotyping for Improved Efficiency and Identification of Stressed Isolates. Pharm. Technol. 28 (3), 156-165 (2004).
  4. Khorzad, A. Khorzad, J. Herche, R.R. Reich and R.A. Caputo. Design and Operational Qualification of a Vapor-Phase Hydrogen Peroxide Biological Indicator Evaluator Resistometer (BIER) Unit. Pharm. Technol. 27 (11), 84-90 (2003).
  5. R.A. Caputo. Validation Testing of a Gas Plasma Sterilization System. Medical Device & Diagnostic Industry, January 1993.
  6. R.A. Caputo. Alternative Sterilization Technologies Come of Age, Gas Plasma Section. Medical Device & Diagnostic Industry, December 1992.
  7. R.A. Caputo. AbTox Plazlyte Plasma Sterilization. Journal of Healthcare Material Management, September 1992.
  8. R.A. Caputo. Biological Monitoring: Is your practice valid as well as cost effective? In 3M Healthcare Quarterly Newsletter, Infection Control Rounds, February 1991.
  9. R.A. Caputo and T.E. Odlaug. Sterilization with Ethylene Oxide and Other Gases. In Disinfection, Sterilization and Preservation. Ed. Seymor S. Block. Third Edition, Chapter 2, 1983.
  10. T.E. Odlaug, V. Jarzynski, R.A. Caputo and C.C. Mascoli. Evaluation of an Automated System for Rapid Identification of Bacillus Biological Indicators and Other Bacillus Species. Journal of Parenteral Science and Technology, March/April 1982.
  11. R.A. Caputo, K.J. Rohn and C.C. Mascoli. Biological Validation of an Ethylene Oxide Sterilization Process. Developments in Industrial Microbiology. Vol. 22, 1981.
  12. T.E. Odlaug, R.A. Caputo and G.S. Graham. Heat Resistance and Population Stability of Lyophilized Bacillus subtilis Spores. Applied and Environmental Microbiology, Vol. 41, 1981.
  13. G.S. Graham, T.E. Odlaug, R.S. Schwabe and R.A. Caputo. Effect of Growth Conditions on Sporulation and Heat Resistance of Bacillus stearothermophilus Spores. ASM Abstract, National Meeting, March 1981.
  14. K.J. Rohn, D.L. Stryker and R.A. Caputo. Ethylene Oxide Resistance and Population Stability of Bacillus subtilis var. niger (globigii) Spores on Various Carrier Materials. ASM Abstract, National Meeting, March 1981.
  15. T.E. Odlaug, R.A. Caputo and G.S. Graham. Heat Resistance and Population Stability of Lyophilized Bacillus subtilis Spores. ASM Abstract National Meeting, March 1981.
  16. R.A. Caputo and C.C. Mascoli. Design and Use of Biological Indicators for Sterilization Cycle Validation. Medical Device and Diagnostic Industry, August 1980.
  17. R.A. Caputo, K.J. Rohn and C.C. Mascoli. Biological Validation of an Ethylene Oxide Sterilization Process. Society for Industrial Microbiology National Meeting August 1980. Developments in Industrial Microbiology, 1981.
  18. T.E. Odlaug, R.A. Caputo and C.C. Mascoli. Determination of Sterilization Values by Microbiological Methods. Society for Industrial Microbiology National Meeting, August 1980. Developments in Industrial Microbiology, 1981.
  19. R.A. Caputo, T.E. Odlaug and C.C. Mascoli. The Effect of Heat Shock Treatment on the D and Z Value of Bacillus Spores. ASM Abstract National Meeting, May 1980.
  20. R.A. Caputo, K.J. Rohn and C.C. Mascoli. Recovery of Biological Indicator Organisms After Sublethal Sterilization Treatment. Journal of Parenteral Drug Association, July/August 1980.
  21. R.A. Caputo. Design and Use of Biological Indicators for Sterilization Cycle Validation. Proceedings of PMA Seminar on Biological Indicators, February 25-27, 1980.
  22. R.A. Caputo, T.E. Odlaug; R.L. Wilkinson and C.C. Mascoli. Biological Validation of a Steam Sterilized Product by the Fractional Exposure Method. Journal of the Parenteral Drug Association, Vol. 33, 4 July/August, 1979.
  23. K.J. Rohn and R.A. Caputo. Post Sterilization Stability of Ethylene Oxide Biological Indicators (B. subtilis var. niger). ASM Abstract, National Meeting, May 1979.
  24. R.A. Caputo, T.E. Odlaug, R.L. Wilkinson and C.C. Mascoli. Biological Validation of a Sterilization Process for a Parenteral Product-Fractional Exposure Approach. ASM Abstract, National Meeting, May 1979.
  25. K.J. Rohn and R.A. Caputo. Post Sterilization Stability of Ethylene Oxide Biological Indicators (B. subtilis var. niger). ASM Abstract, National Meeting, May 1979.
  26. R.A. Caputo, T.E. Odlaug, R.L. Wilkinson and C.C. Mascoli. Biological Validation of a Sterilization Process for a Parenteral Product-Fractional Exposure Approach. ASM Abstract, National Meeting, May 1979.
Verified by MonsterInsights